Clinical Network Services (CNS)

Clinical Network Services (CNS) is an integrated service group focused on product development, headquartered in Australia with offices in New Zealand, the UK and the USA, who create value for small-medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner. 

CNS offers a unique service where it integrates BioDesk, an intelligent global product development and regulatory affairs consultancy, with our committed, highly experienced Australian/ New Zealand clinical services and biometrics teams. CNS’ regional clinical advantage is driven by the extremely pragmatic regulatory environment in Australia and New Zealand that makes it possible for our clients to enter the clinic quickly, without prior regulatory approval.

To learn more about CNS’ uniquely differentiated, customer orientated, suite of services - click on a service area below: